Reynders Mc Veigh Capital Management, LLC Novartis Ag Transaction History

Reynders Mc Veigh Capital Management, LLC

  • $1.74 Billion
  • Q1 2024

A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 121,220 shares of NVS stock, worth $13.1 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
121,220
Previous 125,105 3.11%
Holding current value
$13.1 Million
Previous $12.6 Million 7.17%
% of portfolio
0.68%
Previous 0.8%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$95.27 - $108.47 $11.5 Million - $13.1 Million
121,220 New
121,220 $11.7 Million
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $130,931 - $144,085
-1,419 Reduced 1.12%
125,105 $12.6 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $190,596 - $211,521
-2,012 Reduced 1.57%
126,524 $12.9 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $417,727 - $473,668
-4,515 Reduced 3.39%
128,536 $13 Million
Q1 2023

May 03, 2023
SELL
$80.03 - $92.81 $616,551 - $715,008
-7,704 Reduced 5.47%
133,051 $12.2 Million
Q4 2022

Feb 10, 2023
BUY
$75.55 - $92.52 $86,655 - $106,120
1,147 Added 0.82%
140,755 $12.8 Million
Q3 2022

Nov 08, 2022
BUY
$74.61 - $87.26 $178,094 - $208,289
2,387 Added 1.74%
139,608 $10.6 Million
Q2 2022

Aug 05, 2022
BUY
$80.52 - $93.75 $724,438 - $843,468
8,997 Added 7.02%
137,221 $11.6 Million
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $111,433 - $126,052
-1,391 Reduced 1.07%
128,224 $11.3 Million
Q4 2021

Feb 11, 2022
BUY
$79.7 - $88.13 $21,040 - $23,266
264 Added 0.2%
129,615 $11.3 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $51,521 - $59,938
-630 Reduced 0.48%
129,351 $10.6 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $2.76 Million - $3.05 Million
-32,366 Reduced 19.94%
129,981 $11.9 Million
Q1 2021

May 07, 2021
SELL
$83.5 - $98.47 $2.72 Million - $3.21 Million
-32,595 Reduced 16.72%
162,347 $13.9 Million
Q4 2020

Feb 10, 2021
SELL
$78.07 - $94.43 $409,086 - $494,813
-5,240 Reduced 2.62%
194,942 $18.4 Million
Q3 2020

Oct 28, 2020
SELL
$82.14 - $91.0 $550,748 - $610,155
-6,705 Reduced 3.24%
200,182 $17.4 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $2.89 Million - $3.25 Million
-35,704 Reduced 14.72%
206,887 $18.1 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $753,412 - $1.06 Million
-10,661 Reduced 4.21%
242,591 $20 Million
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $576,954 - $652,330
-6,840 Reduced 2.63%
253,252 $24 Million
Q3 2019

Nov 08, 2019
SELL
$85.54 - $94.26 $1.55 Million - $1.71 Million
-18,146 Reduced 6.52%
260,092 $22.6 Million
Q2 2019

Aug 06, 2019
SELL
$75.4 - $92.8 $1.48 Million - $1.82 Million
-19,603 Reduced 6.58%
278,238 $25.4 Million
Q1 2019

May 10, 2019
BUY
$75.32 - $86.15 $69,520 - $79,516
923 Added 0.31%
297,841 $28.6 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $31,452 - $35,022
-427 Reduced 0.14%
296,918 $25.5 Million
Q3 2018

Nov 26, 2018
BUY
$66.94 - $77.43 $88,026 - $101,820
1,315 Added 0.44%
297,345 $25.6 Million
Q2 2018

Aug 09, 2018
SELL
$64.91 - $73.36 $2.31 Million - $2.61 Million
-35,522 Reduced 10.71%
296,030 $22.4 Million
Q1 2018

Jul 26, 2018
BUY
$70.39 - $84.15 $21.5 Million - $25.6 Million
304,746 Added 1136.86%
331,552 $26.8 Million
Q1 2018

May 03, 2018
SELL
$70.39 - $84.15 $18.8 Million - $22.5 Million
-267,109 Reduced 90.88%
26,806 $332 Million
Q4 2017

Feb 06, 2018
SELL
$72.33 - $77.64 $909,115 - $975,857
-12,569 Reduced 4.1%
293,915 $0
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $733,170 - $764,123
9,889 Added 3.33%
306,484 $26.3 Million
Q2 2017

Aug 14, 2017
BUY
N/A
296,595
296,595 $24.8 Million

Others Institutions Holding NVS

# of Institutions
1,350
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email